Keywords: king, posts, 3rd-qtr, loss, 264m, charge, usa-based
King posts 3rd-qtr loss on $264M charge
Article | 26 November 2007
USA-based King Pharmaceuticals reported a third-quarter 2007 loss of $40.5 million, or $0.17 per share, down from the $90.4 million profit it recorded in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
